Connect with Our Expert
As the global obesity epidemic continues to grow, there is a pressing need for innovative treatments that go beyond current options like GLP-1 receptor agonists. Addressing unmet patient needs and overcoming operational challenges in obesity drug development is crucial to improving outcomes and advancing effective therapies.
Our experts will guide you toward success. We can help you:
- Explore novel mechanisms of action beyond GLP-1s: Get guidance on emerging targets and how to design studies that assess their potential in real-world populations.
- Navigate clinical trial challenges in obesity research: Overcome common roadblocks such as recruitment, retention, and the stigma-related psychological barriers that impact trial success.
- Design efficient, patient-centric trials: Learn how to integrate psychological care and holistic support strategies to elevate patient experience and improve outcomes.
Meet Our Expert:
Ana Gonzalez-Santis, PhD, PMP, Executive Director, Program Strategy, General Medicine
Ready to get started?